TY - JOUR T1 - Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate Cancer JF - Anticancer Research JO - Anticancer Res SP - 5593 LP - 5598 DO - 10.21873/anticanres.15373 VL - 41 IS - 11 AU - LEANDRO BLAS AU - KOSUKE IEIRI AU - MASAKI SHIOTA AU - SHOHEI NAGAKAWA AU - SHIGEHIRO TSUKAHARA AU - TAKASHI MATSUMOTO AU - EIJI KASHIWAGI AU - ARIO TAKEUCHI AU - JUNICHI INOKUCHI AU - KEN-ICHIRO SHIGA AU - AKIRA YOKOMIZO AU - MASATOSHI ETO Y1 - 2021/11/01 UR - http://ar.iiarjournals.org/content/41/11/5593.abstract N2 - Background/Aim: To explore the prognostic value of lower urinary tract symptoms (LUTS) in patients with newly diagnosed regional lymph node-positive prostate cancer. Patients and Methods: The prognostic value of LUTS for progression-free (PFS) and overall (OS) survival, as well as the differential prognostic impact of radiotherapy by LUTS was investigated. Results: Univariate Cox-model analysis showed a statistically significantly increased hazard risk for PFS and OS for men with International Prostate Symptom Score (IPSS)≥19 and Overactive Bladder Symptom Score (OABSS) ≥8 at diagnosis. Patients with lower IPSS had a better PFS at 5 years (70.0% vs. 51.9%, p=0.027) and OS at 5 year (89.3% vs. 73.6%, p=0.016). Similarly, a lower OABSS was associated with greater PFS at 5 years (67.4% vs. 23.4%, p<0.001) and OS at 5 years (85.3% vs. 57.1%, p=0.012). Conclusion: IPSS and OABSS were prognostic for PFS and OS in patients with regional lymph node-metastatic prostate cancer. ER -